# Ketamine for MS Fatigue

> **NCT06064162** · EARLY_PHASE1 · COMPLETED · sponsor: **Alta Bates Summit Medical Center** · enrollment: 21 (actual)

## Conditions studied

- Multiple Sclerosis

## Interventions

- **DRUG:** ketamine

## Key facts

- **NCT ID:** NCT06064162
- **Lead sponsor:** Alta Bates Summit Medical Center
- **Sponsor class:** OTHER
- **Phase:** EARLY_PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2023-12-05
- **Primary completion:** 2025-05-05
- **Final completion:** 2025-05-05
- **Target enrollment:** 21 (ACTUAL)
- **Last updated:** 2025-06-08


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06064162

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06064162, "Ketamine for MS Fatigue". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT06064162. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*